Congenital Long QT Syndrome in Athletes: Screening and Eligibility

Congenital long QT syndrome (LQTS) is an inherited disorder of cardiac repolarisation that can create a risk of torsades de pointes, syncope and sudden cardiac arrest during exercise or emotional stress. Many affected athletes feel entirely well, and a normal physical examination cannot exclude the condition. Preparticipation assessment therefore depends on a careful history, a properly performed 12-lead electrocardiogram (ECG), family evaluation and specialist interpretation.

For Australian athletes, the question is rarely as simple as “play” or “do not play”. Decisions should account for the athlete’s genotype, corrected QT interval (QTc), symptoms, treatment, adherence, sport-specific triggers and access to an emergency response plan. A teenager training for swimming in Brisbane, an AFL player in Melbourne and a recreational runner in Perth may have very different exposure patterns, even when their ECG findings are similar.

Why Long QT Syndrome Matters Before Sport

LQTS results from abnormal ion-channel function, most commonly involving genes such as KCNQ1, KCNH2 and SCN5A. The altered electrical recovery of the ventricles may be visible as QT prolongation on an ECG, although the QTc can fluctuate with heart rate, medications, illness and autonomic tone. Some carriers have a borderline or apparently normal QTc, making clinical context essential.

Exercise increases sympathetic activity and can expose electrical instability. LQT1 is classically associated with exertion, particularly swimming; LQT2 may be triggered by sudden loud noises or intense emotional arousal; and LQT3 events are more often linked with rest or sleep. These patterns are useful clues rather than rigid rules. An athlete can have a different trigger profile, and a negative family history does not rule out a pathogenic variant or an unrecognised sudden death.

Warning signs during preparticipation screening include unexplained fainting, seizure-like episodes, exertional collapse, palpitations with dizziness and near-syncope. The family history should ask specifically about sudden unexplained death, drowning, single-vehicle crashes, resuscitated cardiac arrest and relatives diagnosed with LQTS. In Australia, asking about deaths attributed to “epilepsy” or drowning is particularly important because inherited arrhythmia may have been missed.

Building A Reliable Screening Pathway

A standard preparticipation consultation should record symptoms, previous ECGs, prescribed and non-prescribed medicines, electrolyte disorders and relevant family history. The examination may identify a murmur or another condition, but it is not a substitute for electrical assessment. Athletes with concerning symptoms or family history need prompt medical review rather than clearance based on fitness or appearance.

A resting 12-lead ECG is a sensible first-line test when LQTS is suspected or when local screening protocols include ECG assessment. QT measurement should be performed in appropriate leads and corrected with awareness of the limitations of automated readings and formulas such as Bazett’s. A slow or fast resting heart rate can distort interpretation. Repeat ECGs, exercise testing, ambulatory monitoring and electrolyte testing may be required when the initial result is equivocal.

A borderline QTc should never be treated as an automatic diagnosis or dismissal. Fever, vomiting, diarrhoea, dehydration and low potassium or magnesium can increase arrhythmic risk. Medication review should include antibiotics, antiemetics, psychotropic drugs and antihistamines that may prolong repolarisation. Clinicians can consult a current QT-drug resource and coordinate with a cardiologist before an athlete resumes high-intensity training.

Genetic testing can confirm a molecular diagnosis and support cascade screening of relatives, but a negative result does not exclude LQTS. Conversely, a genetic variant requires careful classification; a variant of uncertain significance should not by itself impose a permanent sporting restriction. Assessment by an inherited arrhythmia service is preferable, especially for children, elite athletes and families with multiple sudden deaths.

Eligibility Should Be Individualised

Participation decisions should be made through shared assessment involving the athlete, family when appropriate, sports physician, electrophysiologist and coaching or welfare staff. Important variables include the QTc, documented arrhythmias, symptoms during exertion, genetic subtype, medication use, implantable cardioverter-defibrillator (ICD) status and the availability of automated external defibrillation. The athlete’s understanding of risk and willingness to follow treatment are also relevant.

Current international approaches have moved away from blanket exclusion based solely on a diagnosis. Many asymptomatic, well-treated athletes can participate in selected competitive or recreational activities after specialist review. High-intensity sport, swimming, diving, solitary exercise and activities in remote environments may demand additional safeguards. The risk assessment should consider the likelihood of an event and the consequences of delayed rescue, rather than relying on a single QTc threshold.

Beta-blockers such as nadolol or propranolol are commonly used in LQTS, with treatment selected and monitored by a specialist. Athletes may experience fatigue, reduced exercise tolerance or difficulty training in hot conditions, which matters during an Australian summer or prolonged outdoor sessions. Medication should not be stopped abruptly to improve performance. Coaches and team doctors should know the prescribed plan, while the athlete should carry reliable medication during travel and competition.

An ICD can reduce mortality after a life-threatening ventricular arrhythmia, but it does not make every sport safe. Contact sports may cause lead damage or pocket trauma, and intense exertion can produce inappropriate shocks. Restrictions should be tailored to the device, the underlying arrhythmia history and the sport’s physical demands. An emergency action plan should identify trained responders, accessible AEDs, ambulance procedures and the location of the nearest hospital.

Australian Considerations For Athletes And Families

Australia’s sporting culture creates distinct practical issues. Swimming clubs, surf lifesaving, school athletics, AFL, rugby, cricket and netball expose young people to different combinations of exertion, heat, water and supervision. A child training before school in Sydney may have easy access to emergency services, while an athlete at a regional carnival or remote surf event may face a longer response time. Eligibility should reflect the actual training and competition environment, not just the sport’s name.

Heat, dehydration and gastroenteritis can worsen electrolyte imbalance. Athletes travelling from Melbourne to Darwin, competing during a Queensland summer or undertaking endurance events in Western Australia need a hydration and illness plan that avoids both dehydration and unsafe overhydration. Vomiting, diarrhoea, fever, faintness or new palpitations should prompt withdrawal from exercise and medical advice. Over-the-counter products should be checked before use because some medicines can lengthen the QT interval.

Screening also has legal and ethical dimensions. The Privacy Act 1988 (Cth), together with applicable state and territory health-records laws, requires careful handling of genetic results, ECGs and family information. Sporting organisations should collect only information needed for safety, restrict access and explain who will receive a medical clearance. The Disability Discrimination Act 1992 (Cth) supports individualised decisions rather than automatic exclusion, while genuine safety requirements may still justify limits supported by specialist evidence.

Medication and competition rules deserve early attention. Beta-blockers are prohibited in some sports under the World Anti-Doping framework, although they are not banned across all disciplines. An athlete may need a Therapeutic Use Exemption, and the process should be started before competition rather than after a test. Sports physicians should check the current Australian anti-doping requirements and document the diagnosis, drug, dose and clinical rationale.

Follow-Up, Education And Research

Clearance is a continuing process, not a once-only certificate. Review should occur after new symptoms, medication changes, an abnormal ECG, an ICD procedure, a significant illness or a change in training intensity. Young athletes need reassessment as they grow, change sports and assume more responsibility for their own treatment. Transition from paediatric to adult inherited-heart services should be planned rather than left until a prescription or competition form is due.

Every participating athlete should know the symptoms that require immediate attention and how to report them. Parents, coaches, lifeguards, teachers and teammates should understand that collapse, seizure-like activity or unresponsiveness during sport is a cardiac emergency. Cardiopulmonary resuscitation and AED training are particularly valuable for swimming clubs, schools and community competitions. An AED should be maintained, visible and reachable within the venue’s emergency response time.

Clinical teams should also discuss family screening. First-degree relatives may require ECG assessment, genetic counselling or testing, even when they are asymptomatic. Results should be explained sensitively because a diagnosis can affect insurance decisions, employment concerns and participation in family activities. Counselling helps relatives understand that a pathogenic variant is a reason for structured care, not a prediction that an event will definitely occur.

For clinicians and researchers, careful reporting of athlete cohorts can improve future eligibility decisions. Manuscripts addressing ECG thresholds, genotype-specific triggers, treatment adherence, ICD outcomes and emergency preparedness should follow the journal’s author guidelines. The field benefits from transparent definitions of exercise exposure, meaningful follow-up and reporting of adverse events, including near-misses and inappropriate restrictions.

The Journal of Arrhythmia’s special issues can also provide a useful route to current discussions in electrophysiology, inherited arrhythmia and sports cardiology. For Australian practice, evidence is most useful when it can be translated into realistic plans for school sport, community clubs, elite programs and remote events.

A safe eligibility decision combines accurate QT assessment, family evaluation, genotype-informed counselling and practical emergency planning. Australian athletes with suspected or confirmed congenital LQTS should be referred to an inherited arrhythmia or electrophysiology service before returning to demanding sport. Clinicians, families and sporting organisations can then support participation wherever the individual risk profile, treatment and rescue capacity make it reasonable.